• Je něco špatně v tomto záznamu ?

Catheter ablation of electrical storm in patients with structural heart disease

M. Kozeluhova, P. Peichl, R. Cihak, D. Wichterle, V. Vancura, J. Bytesnik, J. Kautzner

. 2011 ; 13 (1) : 109-113.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12027320

AIMS: Electrical storm (ES) adversely affects prognosis of patients and may become a life-threatening event. Catheter ablation (CA) has been proposed for the treatment of ES. Our goal was to evaluate the efficacy of CA ablation both in acute and long-term suppression of ES. METHODS AND RESULTS: Fifty consecutive patients with coronary artery disease (38), idiopathic dilated cardiomyopathy (5), arrhythmogenic right ventricular cardiomyopathy (6), and/or with combined aetiology (1) underwent CA for ES. Mean left ventricular ejection fraction (LVEF) was 29 ± 11%. All patients underwent electroanatomical mapping, and CA was performed to abolish all inducible ventricular arrhythmias. The ES was suppressed by CA in 84% of patients. During the follow-up of 18 ± 16 months, 24 patients had no recurrences of any ventricular tachycardia (VT; 48%). Repeated procedure was necessary to suppress the recurrent ES in 13 cases (26%). Statistical analysis revealed that low LVEF (22 ± 3 vs. 31 ± 12%; P < 0.001), increased LVend-diastolic diameter (72 ± 9.1 vs. 64 ± 8.9 mm; P = 0.0135), and renal insufficiency (P < 0.001) were the univariate predictors of early mortality or necessity for heart transplantation. Recurrence of ES despite previous CA procedure was associated with a higher risk of death or heart transplant during follow-up (P < 0.05). CONCLUSION: Catheter ablation is effective in acute suppression of ES and often represents a life-saving therapy. In the long term, it prevents recurrences of any VT in about half of the treated patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027320
003      
CZ-PrNML
005      
20160302140727.0
007      
ta
008      
120816s2011 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1093/europace/euq364 $2 doi
035    __
$a (PubMed)20947570
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Segeťová, Markéta $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Videnska 1958/9, Prague 4 140 21, Czech Republic. mrkz@ikem.cz $7 xx0141757
245    10
$a Catheter ablation of electrical storm in patients with structural heart disease / $c M. Kozeluhova, P. Peichl, R. Cihak, D. Wichterle, V. Vancura, J. Bytesnik, J. Kautzner
520    9_
$a AIMS: Electrical storm (ES) adversely affects prognosis of patients and may become a life-threatening event. Catheter ablation (CA) has been proposed for the treatment of ES. Our goal was to evaluate the efficacy of CA ablation both in acute and long-term suppression of ES. METHODS AND RESULTS: Fifty consecutive patients with coronary artery disease (38), idiopathic dilated cardiomyopathy (5), arrhythmogenic right ventricular cardiomyopathy (6), and/or with combined aetiology (1) underwent CA for ES. Mean left ventricular ejection fraction (LVEF) was 29 ± 11%. All patients underwent electroanatomical mapping, and CA was performed to abolish all inducible ventricular arrhythmias. The ES was suppressed by CA in 84% of patients. During the follow-up of 18 ± 16 months, 24 patients had no recurrences of any ventricular tachycardia (VT; 48%). Repeated procedure was necessary to suppress the recurrent ES in 13 cases (26%). Statistical analysis revealed that low LVEF (22 ± 3 vs. 31 ± 12%; P < 0.001), increased LVend-diastolic diameter (72 ± 9.1 vs. 64 ± 8.9 mm; P = 0.0135), and renal insufficiency (P < 0.001) were the univariate predictors of early mortality or necessity for heart transplantation. Recurrence of ES despite previous CA procedure was associated with a higher risk of death or heart transplant during follow-up (P < 0.05). CONCLUSION: Catheter ablation is effective in acute suppression of ES and often represents a life-saving therapy. In the long term, it prevents recurrences of any VT in about half of the treated patients.
650    _2
$a senioři $7 D000368
650    _2
$a srdeční arytmie $x komplikace $x epidemiologie $7 D001145
650    _2
$a dilatační kardiomyopatie $x komplikace $x epidemiologie $7 D002311
650    _2
$a katetrizační ablace $7 D017115
650    _2
$a komorbidita $7 D015897
650    _2
$a nemoci koronárních tepen $x komplikace $x epidemiologie $7 D003324
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a nemoci srdce $x komplikace $x epidemiologie $7 D006331
650    _2
$a lidé $7 D006801
650    _2
$a Kaplanův-Meierův odhad $7 D053208
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a komorová tachykardie $x epidemiologie $x mortalita $x chirurgie $7 D017180
650    _2
$a výsledek terapie $7 D016896
650    _2
$a fibrilace komor $x epidemiologie $x mortalita $x chirurgie $7 D014693
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Peichl, Petr, $d 1976- $7 xx0092197 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague 4, Czech Republic
700    1_
$a Čihák, Robert $7 xx0061374 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague 4, Czech Republic
700    1_
$a Wichterle, Dan $7 xx0101417 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague 4, Czech Republic
700    1_
$a Vančura, Vlastimil $7 xx0060367 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague 4, Czech Republic
700    1_
$a Bytešník, Jan, $d 1947- $7 jn20000400328 $u Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague 4, Czech Republic
700    1_
$a Kautzner, Josef, $d 1957- $7 xx0037112
773    0_
$w MED00149837 $t Europace European pacing, arrhythmias, and cardiac electrophysiology journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 13, č. 1 (2011), s. 109-113
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20947570 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160302140445 $b ABA008
999    __
$a ok $b bmc $g 949362 $s 784666
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 13 $c 1 $d 109-113 $i 1532-2092 $m Europace $n Europace $x MED00149837
LZP    __
$b NLK112 $a Pubmed-20120816/11/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...